The role of prevalence in the diagnosis of prostate cancer

NB Delongchamps, A Singh, GP Haas - Cancer Control, 2006 - journals.sagepub.com
Background The worldwide incidence of prostate cancer has been rising rapidly, likely due
to intensified effort in early detection and screening. Intense effort is also directed at novel …

Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis

R Damiano, G Di Lorenzo, F Cantiello, M De Sio… - European urology, 2007 - Elsevier
OBJECTIVES: To review all relevant features of incidentally discovered prostate cancer
(PCa) in patients undergoing radical cystectomy for bladder cancer: incidence, pathologic …

Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence

GP Haas, NB Delongchamps, RF Jones… - Journal of the …, 2007 - academic.oup.com
Background It is difficult to estimate the diagnostic accuracy of biopsy for prostate cancer
because men with negative biopsy do not undergo radical prostatectomy and thus have no …

Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer

MJ Roobol, R Kranse, CH Bangma, AG van Leenders… - European urology, 2013 - Elsevier
Background Evidence from randomized trials on the effects of screening for prostate cancer
(PCa) on disease-specific mortality accumulates slowly with increasing follow-up. Objective …

Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy

JA Pettus, H Al-Ahmadie, DA Barocas, TM Koppie… - european urology, 2008 - Elsevier
OBJECTIVES: To determine the incidence and location of prostate adenocarcinoma (PCa)
and prostatic urothelial carcinoma (PUC) for patients undergoing radical cystoprostatectomy …

Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer

V Ananthanarayanan, RJ Deaton, XJ Yang, MR Pins… - BMC cancer, 2006 - Springer
Background Molecular markers identifying alterations in proliferation and apoptotic
pathways could be particularly important in characterizing high-risk normal or pre-neoplastic …

Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant?

R Mazzucchelli, F Barbisan, M Scarpelli… - American journal of …, 2009 - academic.oup.com
Cystoprostatectomy specimens obtained from patients with bladder cancer provide a unique
opportunity to assess the features of silent prostate adenocarcinoma (PCa). The whole …

Determination of optical coefficients and fractal dimensional parameters of cancerous and normal prostate tissues

Y Pu, W Wang, M Al-Rubaiee… - Applied …, 2012 - journals.sagepub.com
Optical extinction and diffuse reflection spectra of cancerous and normal prostate tissues in
the 750 to 860 nm spectral range were measured. Optical extinction measurements using …

Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental …

F Barbisan, R Mazzucchelli, A Santinelli… - European urology, 2009 - Elsevier
BACKGROUND: The human ELAV-like protein HuR regulates the stability of several mRNA
targets, including that of cyclooygenase-2 (COX-2). Their expression in prostatic …

HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected …

R Montironi, R Mazzucchelli, F Barbisan… - Human pathology, 2006 - Elsevier
Previous studies have demonstrated HER2 protein overexpression and/or gene
amplification in a subset of patients with clinically significant prostate cancer (PCa) …